Transforming the CDMO Industry to Improve Patient Access to Medicine
Benefits of our replication approach:
Pushing the industry forward
Expanding patient access
Delivering products to customers with cost & schedule savings
Furthers the goal to deliver products sustainably, predictably, faster, and with flexibility
Fuels innovation and bolster transportability
Contact Us
Learn more
As your global CDMO partner we offer complete solutions in pharmaceutical manufacturing that adapt to your rapidly changing needs – from pre-clinical investigations and process development to flexible commercial cGMP production.
A Unique Value Proposition
Can eliminate the negative impacts of operations and communications variability to manufacturing...becoming a true Partner for Life!
Can erase bottlenecks that impede program progression to scale up or tech transfers
...ramp up to new medicines much faster!
Can harmonize production by standardizing processes for development and manufacturing...to make medicine more accessible!
Can reduce our environmental impact...and challenge the industry standard for more sustainable medicine production!
What is KojoX?
Build capacity with a short deadline
Enable fast ramp up
Utilize existing capacity to its fullest
Through KojoX, we can:
To achieve our objectives, we will:
Build strong organizational capabilities in the projects to deliver faster and cheaper.
Partner across all capabilities and the whole value chain – from development to commercialization.
The underlying strategy for cutting risk, cost, and time is Modularity
Modular Design
A breakdown of scope into standard modules that can be connected in a customized way.
Modular Methodology
A standard factory design that allows you to build factories that are identical.
KojoX Builds on Modularity Across Three Main Functional Areas
Processes
Procedures
Equipment
Click on an area below to learn more.
In place to create customer-specific recipes for fast tech transfers
Standardized and flexible equipment configurations put the customer in charge with fit-for-purpose modules providing fast, low-risk / well-known solutions
Ensure high quality cGxP process execution grounded in experience and expertise
Standard recipe adaptive elements are used in tech transfers to build product-specific recipes
Modular equipment units can be deployed for appropriate scale and modalities as needed
Batch production record modules are standardized and adaptable to different products
KojoXTM in action: flexible facility design through modularity in our Single-Use and Hybrid Network
FUJIFILM Diosynth Biotechnologies selected the capital investment project previously announced for the Billingham, UK, site for the first application of the KojoX operational model in the single-use network to meet customers’ demands. This flexible single-use cell culture facility is scheduled to be operational in 2026.
KojoXTM is optimized manufacturing platforms
We offer flexible production capacity based on optimum combination of Single-use and Stainless-steel technologies
Small 2 x 500 L
Single-Use Systems and Hybrid
Medium 4 x 2K L
Single-Use Systems and Hybrid
Large 6 x 2K L or 2 x 3K L (MB)
Single-Use Systems and Hybrid
4 Pack 4 x 20,000 L
Stainless Steel
Click to learn more
Flexibility for adaptability to scale out and scale up meeting customer demands.
Future-proofing infrastructure for rapid capacity additions as demands dictates.
Improve time-to-market, supply resilience, and geographic diversity of supply.
With KojoX we are transforming the biopharmaceutical industry with the intent to be true Partners for Life across the value chain.
To enable unprecedented quality and delivery performance while reducing environmental impacts
To provide access to advanced technical capabilities and an end-to-end service portfolio from development, to clinical, to commercial, including drug substance, drug product, and finished goods
To enable accelerated timelines for programs moving from development, ensuring seamless progression from clinical to commercial stages
To provide speed and flexibility in scaling up according to demand, ensuring appropriate volumes with a reliable supply
To ensure partner-centric engagement through structured transparent communications
To enable access to scalable capacity based on modular manufacturing suites in one cohesive network
Modular Processes, Equipment and Procedures
Digital Value Chain
End-to-EndPre-Clinical to Commercial
DS DP FG
Network Capacity
Modalities
At Fujifilm we’re adding ADCs to our offerings
The addition of an ADC offering is a natural progression for Fujifilm as it complements our KojoX approach to process development and manufacturing.
KojoXTM is a new level of integration for our global network
Ensured through our global network strategy
AREAS
PURPOSE
EXAMPLE
ADC
An end-to-end network for the medicine's journey through the full product life cycle
Our uniform operating philosophy with a modular approach across sites, scales, modalities, and product life cycle
Leading through value for our partners
Our global network of process and manufacturing capabilities operating in a uniform way
Achieving Value through our Modular Approach
The need for medicine is increasing globally and existing capacity is unable to meet forecasted market demands. We have the stability to withstand market changes.
At the same time the product life cycle of our customers is filled with uncertainty.
Rooted in innovation, FUJIFILM Diosynth Biotechnologies (FDB) is transforming the industry with patients' access to medicine as our driver. Through KojoX we:
The need for medicine is increasing globally and the capacity is unable to meet market demand.
CDMO demand is expected to grow.
At the same time the product life cycle of our customers is filled with uncertainty.
By expanding our capacity fast, help our customers deliver medicine to the world.
We want to be the leading and most trusted CDMO in the pharmaceutical industry!
Build capacity with a short deadline
Enable fast ramp up
Utilize existing capacity to its fullest
Through KojoX, we can:
To achieve our objectives, we will:
Build strong organizational capabilities in the projects to deliver faster and cheaper.
Partner across all capabilities and the whole value chain – from development to commercialization.
The underlying strategy for cutting risk, cost, and time is Modularity
Modular Design
A breakdown of scope into standard modules that can be connected in a customized way.
Modular Methodology
A standard factory design that allows you to build factories that are identical.
How
Why
What
It is our uniform operating philosophy with a modular approach across sites, scales, modalities, and product life cycle to provide our customers the capabilities, speed and flexibility they need to deliver life-changing medicines to their patients.
It is the framework for our aggressive expansion journey in which we build a global network of process and manufacturing capabilities operating in a uniform way to fullfil our commitment to unprecedented delivery – right product, right quantity, right quality, right first time every time.
2 Billion people worldwide do not have access to medicine... and it's only getting worse.
same modular approach
seamless transfer between scales
supply chain flexibility through the lifecycle of the partner program
End-to-End CDMO across different modalities
Embedding Digitalization
across our global network for transparency and consistency
KojoX in action: Our modularity approach increases exponentially, building capacity at unprecedented speed
Click on each Phase to explore our services
You spoke. We listened. We are planning. We are Partners For Life.
As we build it, tell us what you need and join us on this journey.
Our modular approach for designing and building our expansions in Hillerød, DK and Holly Springs, NC, USA, allows us to build exponentially faster as the degrees of replication increase.
Hillerød, DK
Holly Springs, NC, USA
TM